Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/14272/000114036119004566/s002621x29_8k.htm
February 2023
February 2023
January 2023
January 2023
October 2022
July 2022
June 2022
May 2022
April 2022
April 2022
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/14272/000114036119004566/s002621x29_8k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Bristol Myers Squibb Co.
Bristol Myers Squibb Co's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Bristol Myers Squibb Co provided additional information to their SEC Filing as exhibits
Ticker: BMYEvents:
CIK: 14272
Form Type: 8-K Corporate News
Accession Number: 0001140361-19-004566
Submitted to the SEC: Fri Mar 08 2019 7:05:56 AM EST
Accepted by the SEC: Fri Mar 08 2019
Period: Friday, March 8, 2019
Industry: Pharmaceutical Preparations